Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aethlon Medical

0.5432
-0.0093-1.68%
Post-market: 0.5305-0.0127-2.34%19:49 EDT
Volume:829.69K
Turnover:446.87K
Market Cap:4.01M
PE:-0.08
High:0.5754
Open:0.5600
Low:0.5079
Close:0.5525
52wk High:8.44
52wk Low:0.5079
Shares:7.37M
Float Shares:6.62M
Volume Ratio:1.70
T/O Rate:12.54%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.8107
EPS(LYR):-8.5775
ROE:-207.29%
ROA:-63.64%
PB:1.17
PE(LYR):-0.06

Loading ...

Aethlon Medical Inc expected to post a loss of 86 cents a share - Earnings Preview

Reuters
·
Aug 12

Aethlon Medical Inc. Advances Hemopurifier Clinical Trial Following Positive Safety Review, Opens Enrollment for Next Patient Cohort

Reuters
·
Jul 15

Aethlon Medical Coverage Assumed by HC Wainwright & Co. at Neutral

Dow Jones
·
Jul 08

BRIEF-Aethlon Medical Announces Financial Results For Fourth Quarter 2025

Reuters
·
Jun 27

Aethlon Medical Q4 EPS $(3.70) Misses $(1.07) Estimate

Benzinga
·
Jun 27

Aethlon Medical Reports Fiscal Q4 2025 Net Loss of $13.4M, Operating Expenses Down by 26%

Reuters
·
Jun 27

Press Release: Aethlon Medical Announces Financial Results for the Fiscal Fourth Quarter Ended March 31, 2025, and Provides Corporate Update

Dow Jones
·
Jun 27

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Jun 26

Aethlon Medical Inc expected to post a loss of $1.01 a share - Earnings Preview

Reuters
·
Jun 25

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Jun 23

Aethlon Medical Inc. to Announce Fiscal Fourth Quarter Financial Results

Reuters
·
Jun 20

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Jun 20

Aethlon Medical Inc. Announces Progress in Hemopurifier® Cancer Trial with Second Patient Treated in Australia

Reuters
·
Jun 18

Aethlon Medical Announces New Pre-Clinical Data on Hemopurifier® for Long COVID at Keystone Symposium

Reuters
·
Jun 09

Aethlon Medical Inc. Announces 1-for-8 Reverse Stock Split Effective June 9, 2025

Reuters
·
Jun 05

Aethlon Medical Inc. Announces New Clinical Study Highlighting Hemopurifier's Ability to Remove Platelet-Derived Extracellular Vesicles in Ongoing Oncology Trial

Reuters
·
May 14

Aethlon Medical Inc. Conducted Special Stockholders Meeting Virtually

Reuters
·
May 14